T cell memory.
By J. T. Tan, C. Surh. Current Topics in Microbiology and Immunology, 2006
918 citations recorded by the source corpus.
Subfields: Immunology
View Paper: https://www.semanticscholar.org/paper/58840f42b08ad177b2a45af44126ef6ce6778552
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. (2007, background): “Anti-CD44 antibody was also included in the staining cocktail to identify CD44high antigen-experienced cells (Dutton et al., 1998).”
- Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. (2007, background): “Historically, identification of MPECs and SLECs within the effector CD8 T cell population has proven difficult because most of the T cell attributes first studied (e.g. CD44hi and CD11ahi) were acquired uniformly by effector CD8 T cells (Dutton et al., 1998).”
- Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites (2017, background): “While TRMs have been detected in mouse lymph nodes (Schenkel et al., 2014b; Ugur et al., 2014), the majority of mouse lymphoid memory CD4+ and CD8+ T cells in mice are circulating, particularly those in the spleen.”
- Tissue-Resident Memory T Cells (2014, background): “…productively primed within SLOs, they give rise to effector cells that migrate throughout the host and leave behind a memory population that persists long after pathogen clearance (Dutton et al., 1998; Harty and Badovinac, 2008; Lefrançois, 2006; Sallusto et al., 2010; Williams and Bevan, 2007).”
- CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin (2017, positive): “Following in situ activation, Trm cells provide strong defense against recurrent infections (Ariotti et al., 2014; Schenkel et al., 2014).”